Peptide Price Finder

Home · Research · Skin, hair & tanning

Syn-Ake research

What published studies found for Syn-Ake: 3 papers, 1 in humans, with sample sizes and key results.

D
Little or no evidence
Why: Only a computer-modelling and cell study plus uncontrolled studies of a multi-ingredient serum; Syn-Ake's own effect is not isolated.

Syn-Ake (dipeptide diaminobutyroyl benzylamide diacetate), a synthetic mimic of a viper-venom peptide, has almost no published research: one computer-modelling and cell-culture study, and clinical studies of a multi-ingredient serum that also contained argireline, so its own effect cannot be isolated.

? 3 inconclusive

No human adverse-event data are reported in the published abstracts.

Browse and filter these papersSyn-Ake prices and vendors

Human studies

? Inconclusivehuman trialInt J Cosmet Sci · 2026

The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies.

Clinical study 1: n = 50; study 2: n = 42; plus one ex-vivo skin studyOne ex-vivo study and two clinical studies of the combined serum12 weeks of use (static wrinkles)

A serum with acetyl hexapeptide-8, Syn-Ake, gluconolactone, niacinamide and kelp extract improved static wrinkle scores by 35-69% and dynamic wrinkles by 10-13% over 12 weeks in two clinical studies (n=50 and n=42; p<0.001); no placebo comparison is described and several actives were combined.

Key resultStatic wrinkle clinical scoring improved 35% to 69% for various wrinkle types after 12 weeks, and dynamic wrinkles by 10%-13% (all p < 0.001).
Studied
Ex-vivo skin samples and volunteers in two clinical studies of a multi-peptide serum (acetyl hexapeptide-8 and others)
Compared with
Not described in the abstract
Main outcome
Anti-aging biomarkers, clinical scoring of wrinkles and skin quality
Authors' conclusion
The multi-ingredient serum showed significant anti-aging effects on static and dynamic wrinkles and skin quality. Effects cannot be attributed to any single peptide.
Limitations
Combination product; no control group described in the abstract.

Reviews

? InconclusivereviewFacial Plast Surg · 2026

Peptides in Facial Plastic Surgery: Emerging Applications in Aesthetics and Rejuvenation.

No new dataNarrative review for facial plastic surgery practice

Review of cosmetic peptides, including neurotransmitter-inhibiting 'botox-like' peptides: most supporting evidence comes from in vitro and ex vivo work rather than randomized clinical trials.

Studied
Cosmetic and signal peptides including neurotransmitter-inhibiting 'botox-like' peptides
Main outcome
Evidence, mechanisms, safety and efficacy of peptides in skincare
Authors' conclusion
Most supporting evidence comes from in vitro and ex vivo studies rather than randomized clinical trials, and products have limited regulatory oversight.
Limitations
Narrative review with no original data; Vialox not individually assessed in the abstract.

Animal & lab studies

? Inconclusivein vitroJ Biomol Struct Dyn · 2024

Anti-aging activity of Syn-Ake peptide by in silico approaches and in vitro tests.

Cells / labIn silico docking and 50 ns molecular dynamics plus in vitro tests

Docking and molecular-dynamics models predicted binding to MMPs and SIRT1; in the lab Syn-Ake showed concentration-dependent antioxidant (DPPH) activity and was non-cytotoxic and non-mutagenic at the determined safe dose.

Key resultSyn-Ake bound SIRT1 most stably at -9.32 kcal/mol in docking; DPPH radical scavenging increased with concentration.
Studied
Syn-Ake peptide in computer simulations and in vitro assays (cytotoxicity, Ames genotoxicity, DPPH antioxidant)
Main outcome
Binding to MMPs and SIRT1, antioxidant activity, safety
Authors' conclusion
In silico and in vitro results suggest Syn-Ake may hold promise in anti-aging formulations with a high efficacy and safety profile.
Limitations
Computational and in vitro only; no animal or human data.

Verdicts are judged on each paper's own main outcome; grades run from A (strong human evidence) to D (little or none). Details are read from the abstracts, and figures are reproduced only from openly licensed full texts. Not medical advice.